# BGP Stent as Bridging Stent in FEVAR

Study · id `cardio:ct-nct03987035` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03987035](<https://clinicaltrials.gov/study/NCT03987035>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03987035

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

## Technical summary

Registry record NCT03987035. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-18 (actual); primary completion 2022-07-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT03987035, source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)
- Started: 2021-03-18 (actual) (ClinicalTrials.gov record NCT03987035, source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)
- Primary completion: 2022-07-19 (actual) (ClinicalTrials.gov record NCT03987035, source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)
- Completion: 2024-08-31 (actual) (ClinicalTrials.gov record NCT03987035, source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)
- Countries: Germany (ClinicalTrials.gov record NCT03987035, source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03987035-2025-04-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: BGP Stent as Bridging Stent in FEVAR
- Condition: Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture
- Condition: Abdominal Aortic Aneurysm, Without Mention of Rupture
- Intervention (Device): BeGraft Peripheral (BGP) Stent Graft System as bridging stent
- Lead sponsor: Marc Bosiers, MD
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)

## Provenance

Content hash: 1c936fabfc9fd19702257cf286413c1971371022803266e577b60415c0669fb1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
